Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Eli Lilly and Company===Tirzepatide
Entity

Eli Lilly and Company===Tirzepatide

Tracked across 1 events · 21 articles · First seen Mar 04, 2026 · Last active Mar 15, 2026

Sentiment
75
Attention
6
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 75
Tech
GLP-1 Drugs Show Promise in Addiction Treatment
Eli Lilly and Company===Tirzepatide, another GLP-1 drug, demonstrates similar efficacy to Novo Nordisk===Semaglutide in preventing and treating substance use disorders, suggesting a broader application and increased demand.
Mar 04, 2026 · 21 articles
Relationships (2)
United States===VA St. Louis Health Care System ↔ Eli Lilly and Company===Tirzepatide Unknown
Novo Nordisk===Semaglutide ↔ Eli Lilly and Company===Tirzepatide Unknown
NEWSDESK
Track Eli Lilly and Company===Tirzepatide live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.